| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K19103580 |
| PharmacoGx | BRD-K19103580 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ACP1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | ACP6 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | ACP7 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | ACSL3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | ACTA2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | ACTG2 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | ACTL6A | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | ACTL7A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ACTL7B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
